Arkolith/Insider Trading/RGRX/Form 4

Cavazza Paolo

10% OwnerREGENERX BIOPHARMACEUTICALS INC (RGRX) · full profile →Form 4 · filed Jul 2, 2021
Net Buying
Open-Market Buys
$300K
Open-Market Sells
$0
Net Open-Market Flow
$300K
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 30, 2021Buy(P)1.5M$0.20$300K1.5M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 30, 2021Other(J)1.1M——1.1M
Jun 30, 2021Other(J)1.1M——1.1M

Transaction Codes

P
Open-market purchase
J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-21-035569) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML